| # | Country | Total Patents | |
|---|---|---|---|
| #1 | New Zealand | 11 | |
| #2 | EPO (European Patent Office) | 9 | |
| #3 | China | 8 | |
| #4 | Republic of Korea | 8 | |
| #5 | Australia | 7 | |
| #6 | United States | 7 | |
| #7 | WIPO (World Intellectual Property Organization) | 7 | |
| #8 | Canada | 6 | |
| #9 | Mexico | 5 | |
| #10 | Brazil | 4 | |
| #11 | EAPO (Eurasian Patent Organization) | 4 | |
| #12 | Japan | 3 | |
| #13 | Chile | 2 | |
| #14 | Israel | 2 | |
| #15 | Morocco | 2 | |
| #16 | Taiwan | 2 | |
| #17 | Ukraine | 2 | |
| #18 | South Africa | 2 | |
| #19 | Hong Kong | 1 | |
| #20 | Singapore | 1 | |
| #21 | Tunisia | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Analysing materials | |
| #5 | Unspecified technologies | |
| #6 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Doyle Anthony Gerard | 58 |
| #2 | Jennings Philip Anthony | 49 |
| #3 | Clarke Adam William | 39 |
| #4 | Pollard Matthew | 27 |
| #5 | Kienzle Norbert Alexander | 22 |
| #6 | Pow Andrew James | 17 |
| #7 | Poulton Lynn Dorothy | 17 |
| #8 | Tomlinson Ian M | 15 |
| #9 | Woolven Benjamin P | 14 |
| #10 | Lee Jennifer A | 12 |
| Publication | Filing date | Title |
|---|---|---|
| CN103429261A | Modified antibody with improved half-life | |
| MX2013000727A | Anti-il-23 heterodimer specific antibodies. | |
| CA2778552A1 | Treatment of cancer involving mutated kras or braf genes | |
| EP2433967A2 | Humanised antibodies with anti-tumour activity | |
| BRPI0917668A2 | antibody, method for producing the antibody, nucleic acid molecule, method for treating a disease, use of an antibody, and method for producing an antigen binding domain | |
| UA104297C2 | Anti-il-12/il-23 antibody | |
| WO2010017595A1 | Variant domain antibodies | |
| EP2066696A1 | Anti-cancer antibodies against lewisy and lewisb antigens | |
| NZ569406A | Chimeric antibodies with part new world primate binding regions | |
| AU2006281980A1 | Engineered antibodies with new world primate framework regions |